2017
DOI: 10.1016/j.mehy.2017.01.017
|View full text |Cite
|
Sign up to set email alerts
|

Could mucin 16 and colony-stimulating factor 2-receptor beta possible graft versus host disease biomarkers? Medical hypotheses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 17 publications
0
5
0
Order By: Relevance
“…Differently expressed proteins in UWS of adults with mucosal GVHD compared with patients without GVHD or healthy controls included IL-1 receptor antagonist, cystatin-B, lactoperoxidase, and lactotransferrin (Table 2) [27,28]. Mucin 16 and colony-stimulating factor 2 receptor b were also differentially expressed between adults with cGVHD (oral symptoms not specified) and healthy controls ( Table 2) [44]. Moreover, 3 proteins S100A7, S100A8, and S100A9 short were differentially expressed between allogeneic patients with GVHD and those without GVHD and healthy individuals in a study including children age 14 years [45].…”
Section: Saliva Compositionmentioning
confidence: 99%
“…Differently expressed proteins in UWS of adults with mucosal GVHD compared with patients without GVHD or healthy controls included IL-1 receptor antagonist, cystatin-B, lactoperoxidase, and lactotransferrin (Table 2) [27,28]. Mucin 16 and colony-stimulating factor 2 receptor b were also differentially expressed between adults with cGVHD (oral symptoms not specified) and healthy controls ( Table 2) [44]. Moreover, 3 proteins S100A7, S100A8, and S100A9 short were differentially expressed between allogeneic patients with GVHD and those without GVHD and healthy individuals in a study including children age 14 years [45].…”
Section: Saliva Compositionmentioning
confidence: 99%
“…Consequently, it offers an alternative and accessible resource for biomarker discovery. To date, the few published proteomic studies screening saliva for oral cGVHD biomarkers have used pooled patient samples (Bassim et al, 2012;Chiusolo et al, 2013;Devic et al, 2014;Souza et al, 2017) with variable methods and outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…We acknowledge that salivary gland damage might be due to the conditioning regimes, unspecific trauma, and a response of overall cGVHD, which is difficult to determine but it highlights the need for large cohort defined clinicopathological studies. Thus, it is crucial to identify early diagnostic criteria for sg-cGVHD and saliva biomarkers could potentially serve this purpose in the future [ 40 , 41 ].…”
Section: Discussionmentioning
confidence: 99%